F-18 FLT PET: A Noninvasive Diagnostic Tool for Visualization of the Bone Marrow Compartment in Patients With Aplastic Anemia: A Pilot Study

Rationale: A discordant relationship between bone marrow cellularity and peripheral blood findings is regularly noticed in patients with aplastic anemia (AA). Therefore, the feasibility of 3-F-18 fluoro-3-deoxy-L-thymidine (F-18 FLT PET was tested as a noninvasive tool to visualize the total distribution of the hematopoietic bone marrow compartment in AA at presentation or after treatment. Methods: In vivo scanning was performed with F-18 FLT PET in AA patients (n = 17), including patients upfront (n = 11) and following treatment (n = 6), in addition to peripheral blood cell counts and a bone marrow biopsy. Results: A striking abnormal F-18 FLT scan was observed in all patients upfront treatment, in particular a reduced uptake of the pelvis was shown, the area that is biopsied for the bone marrow biopsy. Following treatment, the number of solitary lesions with increased proliferative activity outside the pelvis was noticed in patients with partial response, whereas patients with a complete remission showed a homogenous uptake throughout the skeleton. Conclusion: This pilot study demonstrates that F-18 FLT scan provides a highly distinctive overview of the bone marrow compartment in AA that might be helpful for making a proper diagnosis and monitoring treatment response of AA patients.

[1]  H. Hoekstra,et al.  Positron emission tomography in patients with breast cancer using (18)F-3'-deoxy-3'-fluoro-l-thymidine ((18)F-FLT)-a pilot study. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  N. Young,et al.  Current concepts in the pathophysiology and treatment of aplastic anemia. , 2013, Hematology. American Society of Hematology. Education Program.

[3]  P. Price,et al.  The uptake of 3′-deoxy-3′-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  H. Hoekstra,et al.  [18F]FLT-PET in oncology: current status and opportunities , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  M. Westerman,et al.  An evaluation of cellularity in various types of bone marrow specimens. , 1979, American journal of clinical pathology.

[6]  D. Marciano,et al.  Evaluation of aplastic anemia with indium chloride In 111 scanning. , 1980, Archives of internal medicine.

[7]  A. Shields,et al.  Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo. , 2000, Nuclear medicine and biology.

[8]  E. Vellenga,et al.  Autologous Stem Cell Transplantation Induces a Phenotypical Shift From CMP to GMP Progenitors, Reduces Clonogenic Potential and Enhances in Vitro and In Vivo Cycling Activity Defined by 18f-FLT PET Scan. , 2009 .

[9]  Otto Muzik,et al.  Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.

[10]  F. Jamar,et al.  Scintigraphic evaluation of the haemopoietic bone marrow using a 99mTc‐anti‐granulocyte antibody: a validation study with 52Fe , 1995, British journal of haematology.

[11]  E. Vellenga,et al.  18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  D. Lee,et al.  Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  E. Kansu,et al.  Aplastic anaemia with 'hot pockets'. , 2009, Scandinavian journal of haematology.

[14]  W. Vaalburg,et al.  18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  H. Barthel,et al.  Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. , 2006, Cancer research.

[16]  L. Wiens,et al.  Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Wesseling,et al.  Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.